Isodiol International LLC (CSE:ISOL, OTC:LAGBF, FSE:LBGA.F), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that the Company has signed a letter of intent (LOI) to acquire 100% of KURE Corp, a leading specialty vape retailer headquartered in Charlotte, North Carolina, with locations in the United States and annualized unaudited Fiscal 2018 revenue of $8.8m USD.The post Isodiol International Inc. Signs Letter of Intent to Acquire Leading Specialty Vape Retailer KURE Corp appeared first on Investing News Network.